IRIS
GNECCHI, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.203
AS - Asia 4.567
EU - Europa 3.723
SA - Sud America 638
Continente sconosciuto - Info sul continente non disponibili 237
AF - Africa 188
OC - Oceania 12
Totale 16.568
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.904
CN - Cina 2.011
SG - Singapore 1.075
IE - Irlanda 825
IT - Italia 651
HK - Hong Kong 493
BR - Brasile 479
RU - Federazione Russa 439
DE - Germania 436
VN - Vietnam 404
FI - Finlandia 377
UA - Ucraina 242
FR - Francia 212
GB - Regno Unito 154
CA - Canada 136
IN - India 132
SE - Svezia 121
ZA - Sudafrica 109
BD - Bangladesh 70
MX - Messico 60
AR - Argentina 56
JP - Giappone 56
AT - Austria 48
PL - Polonia 41
TR - Turchia 41
ID - Indonesia 40
NL - Olanda 38
BE - Belgio 34
ES - Italia 31
IQ - Iraq 30
EC - Ecuador 27
CO - Colombia 23
MY - Malesia 23
PH - Filippine 22
PK - Pakistan 20
SA - Arabia Saudita 18
VE - Venezuela 18
IL - Israele 16
KE - Kenya 16
AE - Emirati Arabi Uniti 15
JO - Giordania 14
TT - Trinidad e Tobago 14
CR - Costa Rica 13
NI - Nicaragua 13
LT - Lituania 12
MU - Mauritius 12
UZ - Uzbekistan 12
JM - Giamaica 11
MA - Marocco 11
CL - Cile 10
AU - Australia 9
HN - Honduras 9
KR - Corea 9
AL - Albania 8
CH - Svizzera 8
EG - Egitto 8
GT - Guatemala 8
PE - Perù 8
PY - Paraguay 8
SV - El Salvador 8
TN - Tunisia 8
BO - Bolivia 7
CW - ???statistics.table.value.countryCode.CW??? 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
IR - Iran 6
NP - Nepal 6
PR - Porto Rico 6
PT - Portogallo 6
SC - Seychelles 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
EU - Europa 5
GP - Guadalupe 5
KG - Kirghizistan 5
SN - Senegal 5
TH - Thailandia 5
EE - Estonia 4
KZ - Kazakistan 4
LB - Libano 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
AO - Angola 3
BB - Barbados 3
BY - Bielorussia 3
CM - Camerun 3
HR - Croazia 3
KW - Kuwait 3
MK - Macedonia 3
RO - Romania 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BH - Bahrain 2
CY - Cipro 2
GE - Georgia 2
GI - Gibilterra 2
LV - Lettonia 2
Totale 16.317
Salva come PNG Salva come JPEG
Città #
Dublin 824
San Jose 749
Chandler 686
Ashburn 677
Singapore 593
Hong Kong 480
Dallas 429
Beijing 425
Nanjing 363
Council Bluffs 340
Jacksonville 322
New York 210
Boardman 200
Los Angeles 174
Helsinki 166
Wilmington 147
Princeton 145
Ho Chi Minh City 136
Lauterbourg 136
Lawrence 135
Nanchang 132
Munich 122
Hanoi 104
Changsha 103
Hebei 103
Pavia 101
Johannesburg 96
Shenyang 95
Medford 92
Shanghai 87
Jiaxing 86
Milan 78
Moscow 77
Ann Arbor 76
Hangzhou 71
Santa Clara 70
Buffalo 69
São Paulo 59
Redondo Beach 54
Nuremberg 53
Tokyo 49
Orem 45
Tianjin 45
Toronto 43
Turku 43
Frankfurt am Main 35
Warsaw 34
Brooklyn 33
Montreal 32
Denver 31
Brussels 29
Rome 28
Woodbridge 28
Chennai 27
The Dalles 27
Norwalk 26
Atlanta 24
North Bergen 24
London 23
Chicago 22
Dearborn 22
Falls Church 22
Columbus 21
Guangzhou 21
Boston 20
Fairfield 20
Mexico City 20
Phoenix 20
Seattle 20
Washington 20
Houston 19
Rio de Janeiro 19
Verona 19
Vienna 19
Da Nang 18
Falkenstein 18
Belo Horizonte 17
Haiphong 17
Mumbai 16
Amsterdam 15
Bologna 15
Piscataway 15
San Francisco 15
Ankara 14
Nairobi 14
Zhengzhou 13
Amman 12
Baghdad 12
Managua 12
Manchester 12
Naples 12
Poplar 12
Quito 12
Stockholm 12
Florence 11
Miami 11
Palermo 11
Brasília 10
Caracas 10
Chieti 10
Totale 10.341
Salva come PNG Salva come JPEG
Nome #
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 276
Cellule staminali mesenchimali fetali isolate da placenta esercitano effetti paracrini cardioprotettivi. 213
Allogeneic Lethally Irradiated Cord Blood Mononuclear Cells in No-Option Critical Limb Ischemia: A “Box of Rain” 174
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 173
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 173
Concomitant overexpression of IGF1 and BMP2 in mesenchymal stem cells mediates cytoprotection through both autocrine and paracrine activation of Akt, Erk1/2 and SMAD1/5/8 pathways. 163
Novel experimental protocol to study area at risk, infarct size, immunohistochemistry and tissue protein content on the same rodent heart. 148
Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis 147
Improved transduction efficiency of human amniotic mesenchymal stem cells using optimized lentiviral vectors 147
Identificazione di fattori paracrini e cardioprotettivi mediante analisi combinata del trascrittoma e del proteoma di cellule staminali mesenchimali fetali. 145
Rat experimental model of myocardial ischemia/reperfusion injury: an ethical approach to set up the analgesic management of acute post-surgical pain 144
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 143
Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation 143
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 142
Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 140
Combined transcriptomic and proteomic approach identifies several putative paracrine factors of fetal mesenchymal stem cells. 138
Paracrine mechanisms of mesenchymal stem cells in tissue repair 138
Mesenchymal stem cell therapy for heart disease. 137
Amyloidogenic light chains induce human cardiac fibroblast toxicity through alteration of mitochondrial functionality 137
Impiego di cellule staminali mesenchimali in cardiologia. 137
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 134
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 132
Adult stem cell-based therapy for the heart 132
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 130
Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 127
Human fetal mesenchymal stem cells protect cardiac myocytes against hypoxia/reoxygenation injury 127
Testing the paracrine properties of human mesenchymal stem cells using conditioned medium 127
Overexpression of growth factors to improve cardiac differentiation of human mesenchymal stem cells derived from the amniotic membrane 127
Angiography- versus physiology-guided complete revascularization in patients with STEMI and multivessel disease: who's the better gatekeeper in this setting? 127
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and platelets 126
Donor Age Negatively Influences Cytoprotective but Not Proangiogenic Paracrine Properties of Human Mesenchymal Stem Cells. 126
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 126
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 125
Studio pilota sull'impiego di cellule CD133+ immunoselezionate per il trattamento di vasculopatie periferiche. 125
Identification of cardioprotective factors produced by fetal mesenchymal stem cells through a combined transcriptomic and proteomic approach. 125
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 125
Cord blood derived endothelial progenitor cells: time dependent in vitro generation capacity. 124
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 123
Enhancing the cardiomyogenic potential of human mesenchymal stem cells by modulation of miR expression. 123
Cord blood-derived endothelial progenitor cells: a superior building company in the angiogenesis market: P599 123
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 122
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 122
Protocols for in vitro differentiation of human mesenchymal stem cells into osteogenic, chondrogenic and adipogenic lineages 121
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution 121
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 121
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 120
PBMC microRNA-155 is up-regulated in chronic hemodialysis patients. 119
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 118
L'età influenza negativamente gli effetti paracrini caridoprotettivi mediati da cellule staminali mesenchimali. 117
Cord blood derived endothelial progenitor cells: a superior buiding company in angiogenesis market. 117
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 117
Gene and cell-based therapies for heart disease 116
Soluble factors released by human mesenchymal stem cells of fetal origin lead to cardiomyocyte protection through the inhibition of pro-apoptotic signaling 116
Enhancing stem cell therapy efficacy through genetic modification 116
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 116
Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis 116
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 115
IRES-based lentivirus co-espressing TGFbeta1 and FGF2 improves cell survival and angiogenesis in bone marrow-derived mesenchymal stem cells. 114
microRNA and Cardiac Regeneration 114
Pentraxin-3 and galectin-1 are key mediators of the cardioprotective paracrine effects exerted by fetal mesenchymal stem cells isolated from human placenta 114
Proteotoxicity in cardiac amyloidosis: Amyloidogenic light chains affect the levels of intracellular proteins in human heart cells 114
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 114
First-in-man case of non-invasive proton radiotherapy for the treatment of refractory ventricular tachycardia in advanced heart failure 112
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 111
MicroRNA133 and microRNA499 exert synergistic effect on cardiac differentiation 111
La contemporanea overespressione di miRNA499 e miRNA133 induce il differenziamento in senso cardiomiocitario di cellule staminali pluripotenti. 110
Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction 110
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 110
Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes, Transgenic Rabbits, and Patients 110
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell mediated cardiac repair and functional improvement 108
Novel IRES-based lentivirus co-expressing IGF1 and BMP2 enhances both cardiomyogenesis and cytoprotection of bone marrow-derived mesenchymal stem cells 108
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations 108
Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy. 108
Long QT Syndrome modelling with cardiomyocytes derived from human-induced pluripotent stem cells 107
The unfavourable inflammatory response in elderly patients after myocardial infarction: should we talk of 'dysflammaging'? 107
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 106
Leptin affects the inflammatory response after STEMI 106
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1 105
Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes? 105
Mesenchymal stem cell therapy for heart disease. 104
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population 104
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 104
Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction and conditioned media production 103
Optimized lentiviral transduction of human amniotic mesenchymal stromal cells 102
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 102
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease 101
Neutrophil to platelet ratio: a novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention 101
Soluble factors released by human mesenchymal stem cells of fetal origin lead to cardiomyocyte protection through the inhibition of pro-apoptotic signaling 100
Barriers associated with emergency medical service activation in patients with ST-segment elevation acute coronary syndromes 100
Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries 98
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 98
Insertion/deletion polymorphism of the Angiotensin I-Converting Enzyme gene and risk of restenosis after directional coronary atherectomy followed by stent implantation 97
Cell Therapy for Heart Regeneration: Learning from the Past to Build a Brighter Future 97
Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock 95
Identification of upregulated microRNAs in the plasma of patients with acute myocardial infarction 95
Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias 95
Association of Troponin Levels with Mortality in Italian Patients Hospitalized with Coronavirus Disease 2019: Results of a Multicenter Study 93
the procardiomyogenic effect of miR499 is sinergistically enhanced by miR133. 93
The prognostic value of serial troponin measurements in patients admitted for COVID-19 93
Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection 92
Totale 12.181
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.457
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.457
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022540 0 0 0 0 15 23 9 46 45 16 92 294
2022/20232.151 225 155 37 131 207 211 5 116 950 22 55 37
2023/2024953 99 177 33 62 84 270 33 52 6 40 56 41
2024/20252.482 63 173 37 55 79 148 160 162 625 77 312 591
2025/20265.801 498 429 611 580 760 227 1.044 272 616 423 186 155
2026/20271.667 104 317 432 509 305 0 0 0 0 0 0 0
Totale 16.568